BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38358044)

  • 21. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
    Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
    Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of glutathione S-transferase A3 in the progression of cutaneous squamous cell carcinoma.
    Li W; Qiu C; Wang S; Wu L; Zhao T
    J Cosmet Dermatol; 2021 Jul; 20(7):2287-2295. PubMed ID: 33089654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sanguinarine Triggers Apoptosis in Cutaneous Squamous Cell Carcinoma Cells through Reactive Oxygen Species-Dependent c-Jun N-Terminal Kinase Signaling Pathway.
    Patil K; Khan AQ; Ahmad F; Kuttikrishnan S; Anver R; Mateo JM; Ahmad A; Bhat AA; Buddenkotte J; Steinhoff M; Uddin S
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):40. PubMed ID: 38287817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN.
    Bai X; Zhou Y; Chen P; Yang M; Xu J
    J Cell Biochem; 2018 Feb; 119(2):2179-2188. PubMed ID: 28857248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
    Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nr5a2 promotes tumor growth and metastasis of gastric cancer AGS cells by Wnt/beta-catenin signaling.
    Liu L; Li Y; Pan B; Zhang T; Wei D; Zhu Y; Guo Y
    Onco Targets Ther; 2019; 12():2891-2902. PubMed ID: 31114234
    [No Abstract]   [Full Text] [Related]  

  • 30. Dihydroartemisinin suppresses growth of squamous cell carcinoma A431 cells by targeting the Wnt/β-catenin pathway.
    Hui HY; Wu N; Wu M; Liu Y; Xiao SX; Zhang MF
    Anticancer Drugs; 2016 Feb; 27(2):99-105. PubMed ID: 26457547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
    Hou Z; Wu C; Tang J; Liu S; Li L
    Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
    Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
    J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
    Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
    J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.
    Chen W; Leiter A; Yin D; Meiring M; Louw VJ; Koeffler HP
    Int J Oncol; 2010 Sep; 37(3):737-43. PubMed ID: 20664943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artesunate restrains the malignant progression of human cutaneous squamous cell carcinoma cells via the suppression of the PI3K/AKT pathway.
    Huang X; Zhang S; Wang W
    Tissue Cell; 2022 Jun; 76():101789. PubMed ID: 35338984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
    Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
    J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
    Wu N; Hui H; Cui L; Yang F
    Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HOXA5 inhibits the proliferation and metastasis of cervical squamous cell carcinoma by suppressing the β-catenin/Snail signaling.
    Jin WY; Zhang Y; Tian J; Xu LK; Lin HJ; Yang YZ; Zhang XM; Jin MH; Mo WF; Qi GY; Zhou YQ
    Neoplasma; 2023 Feb; 70(1):82-93. PubMed ID: 36660797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [hsa_circ_0000231 affects the progression of tongue squamous cell carcinoma by activating Wnt/β-catenin signaling pathway].
    Chen QW; Wang DQ; Ding BX; Tang MM; Li XG; Zhou JY; Xu K; Fang ZR; Han L; Wu H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1230-1239. PubMed ID: 36319130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.